UNDER NEW OWNERSHIP AND MANAGEMENT since 2019, KRS Global Biotechnology is an FDA and DEA registered 503B Human Outsourcing Facility that provides sterile intravenous compounded products to hospitals, surgery centers, medical clinics, and medical institutions nationwide.